CAS 121032-29-9
:Nelarabine
Description:
Nelarabine is a synthetic nucleoside analog primarily used in the treatment of certain types of leukemia, particularly T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma. Its chemical structure is derived from the purine nucleoside guanosine, and it functions as an antimetabolite, interfering with DNA synthesis and repair. The compound is administered intravenously and is known for its ability to penetrate the central nervous system, making it effective against leukemic cells that may infiltrate this area. Nelarabine is characterized by its specific mechanism of action, which involves the conversion to its active form, ara-GTP, that inhibits DNA polymerase and ultimately leads to cell death. Common side effects include myelosuppression, neurotoxicity, and infections due to its impact on the immune system. As a targeted therapy, nelarabine represents a significant advancement in the treatment of hematological malignancies, offering hope for patients with relapsed or refractory disease. Its development underscores the importance of nucleoside analogs in modern oncology.
Formula:C11H15N5O5
InChI:InChI=1/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1
InChI key:InChIKey=IXOXBSCIXZEQEQ-UHTZMRCNSA-N
SMILES:O[C@@H]1[C@H](N2C=3C(N=C2)=C(OC)N=C(N)N3)O[C@H](CO)[C@H]1O
Synonyms:- 9-β-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
- MAY
- Nelzarabine
- 506u
- 9H-Purin-2-amine, 9-β-D-arabinofuranosyl-6-methoxy-
- NELARABINE
- Nelzarabine [USAN]
- 9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
- (2R,3R,4S,5R)-2-(2-aMino-6-Methoxy-9H-purin-9-yl)-5-(hydroxyMethyl)-tetrahydrofuran-3,4-diol
- 9-(D-arabinofuranosyl)-6-methoxy-9H-purin-2-amine
- 9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS:Formula:C11H15N5O5Purity:98%Color and Shape:SolidMolecular weight:297.2673(2R,3S,4S,5R)-2-(2-Amino-6-Methoxy-9H-Purin-9-Yl)-5-(Hydroxymethyl)Tetrahydrofuran-3,4-Diol
CAS:<p>(2R,3S,4S,5R)-2-(2-Amino-6-Methoxy-9H-Purin-9-Yl)-5-(Hydroxymethyl)Tetrahydrofuran-3,4-Diol</p>Purity:98%Molecular weight:297.27g/molNelarabine
CAS:<p>Nelarabine (GW 506U78) is a purine nucleoside analog and DNA synthesis inhibitor with IC50 from 0.067-2.15 μM in tumor cells.</p>Formula:C11H15N5O5Purity:98.10% - 99.6%Color and Shape:White SolidMolecular weight:297.27Nelarabine
CAS:<p>Nelarabine is a drug that prevents the growth of cells by inhibiting the bcr-abl kinase, which is an intracellular target. This drug has been shown to be effective against pediatric patients with t-cell acute lymphoblastic leukemia and adults with chronic myeloid leukemia. Nelarabine has minimal toxicity in humans and is not toxic to healthy cells. It has been shown to have anti-inflammatory properties and may be used as a biomarker for autoimmune diseases. Nelarabine also inhibits angiogenesis, which may be due to its effects on nuclear DNA.</p>Formula:C11H15N5O5Purity:Min. 95%Color and Shape:White PowderMolecular weight:297.27 g/molNelarabine
CAS:Controlled Product<p>Applications A chemotherapy drug used in the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).<br>References Cohen, M.H. et al.: Oncologist, 13, 709 (2008); Hernandez-Ilizaliturri, F.J. et al.: Clin. Med. Therap., 1, 505 (2009); Sigalas, P. et al.: Leuk. Res., 33, e61 (2009);<br></p>Formula:C11H15N5O5Color and Shape:WhiteMolecular weight:297.27






